Oncology trials present unique challenges — no other therapeutic area is so universally time- and resource-intensive. While working with sensitive patient populations, developers also face unique regulatory challenges and opportunities for drugs that may be eligible for expedited approval.

Clinlogix provides Phase I-IV oncology support, including targeted drug/biologic delivery, for research programs worldwide. With teams structured to work quickly and closely with you and your sites, we reinforce effective trial planning and execution from protocol development to database lock.

We have successfully executed commercial and investigator-initiated oncology trials for the following indications:

Oncology Experience

  • Bladder cancer
  • Breast cancer
  • Cervix cancer
  • Colon/rectal cancer
  • Lung cancer
  • Ovarian cancer
  • Pancreatic cancer
  • Prostate cancer